Summary

AI-generated

This summary is written by a language model reading the source document. It is not the publisher's words and is not a substitute for the original.

Learn more about AI enrichment

The author contends that governments in developing nations, especially across Africa, undermine global efforts to lower drug prices by imposing high tariffs and sales taxes on medicines. These financial barriers disproportionately affect the poorest citizens, such as HIV-positive patients in South Africa, by making life-saving treatment unaffordable and reducing the funds available for nutrition. The paper highlights that a 1% reduction in tariffs correlates with a 1% increase in medicine access. Beyond taxation, the author criticizes 'burdensome bureaucracy' in countries like South Africa and Namibia, where slow registration processes and redundant regulations delay patient access to drugs. The document calls for the urgent removal of these 'pernicious taxes and tariffs' and the reform of medical bureaucracies to improve healthcare outcomes.

Key insights

AI-generated

These insights are written by a language model reading the source document. They are not the publisher's words and are not a substitute for the original.

Learn more about AI enrichment
  • Governments in poor countries often impose high taxes and tariffs on medicines and medical supplies, effectively funding themselves by taxing the most vulnerable citizens.
  • There is a significant statistical relationship between tariff rates and the availability of essential medicines, where a 1% decrease in tariffs leads to a 1% increase in access.
  • Several countries, including Kenya, Tanzania, Uganda, India, Nigeria, Brazil, and Morocco, have imposed financial barriers to medicine exceeding 27%.
  • In South Africa, sales tax on antiretroviral therapy can create a financial trade-off where patients cannot afford adequate nutrition, which is critical for the survival of HIV patients.
  • International donors and organizations are increasingly conditioning aid on the removal of medical tariffs; for example, the Global Fund and a proposed US bill ('The Neglected Disease Results Act of 2005') seek to outlaw donations to countries that tax donated medicines.
  • Bureaucratic inefficiencies in South Africa can delay the authorization of medicines already registered in the US, EU, and Japan for more than two years.
  • Namibia implemented a redundant regulation requiring the re-registration of all medicines that had been registered prior to its independence in 1990.

Cite the original document

APA
South African Institute of International Affairs (2008). Taxing Africa to Death. https://saiia.org.za/research/comment-taxing-africa-to-death/
Chicago
South African Institute of International Affairs. Taxing Africa to Death. 2008. https://saiia.org.za/research/comment-taxing-africa-to-death/.
Wikipedia
{{cite report |author=South African Institute of International Affairs |title=Taxing Africa to Death |date=25 April 2008 |url=https://saiia.org.za/research/comment-taxing-africa-to-death/ |access-date=17 August 2026 |via=Climate Insights Directory}}
BibTeX
@techreport{southafricaninstituteofinternationalaffairs2008taxing, author = {{South African Institute of International Affairs}}, title = {{Taxing Africa to Death}}, institution = {South African Institute of International Affairs}, year = {2008}, month = apr, url = {https://saiia.org.za/research/comment-taxing-africa-to-death/}, urldate = {2026-08-17}, note = {Indexed by Climate Insights Directory} }

Full text

Collected · Record updated